Independent Director of Ginkgo Bioworks Holdings Shyam Sankar Buys 32% More Shares \

Those following along with Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) will no doubt be intrigued by the recent purchase of shares by Shyam Sankar, Independent Director of the company, who spent a stonking US$512k on stock at an average price of US$1.28. Aside from being a solid chunk in its own right, the deft move also saw their holding increase by some 32%.

See our latest analysis for Ginkgo Bioworks Holdings

The Last 12 Months Of Insider Transactions At Ginkgo Bioworks Holdings

In the last twelve months, the biggest single sale by an insider was when the Founder, Jason Kelly, sold US$1.2m worth of shares at a price of US$2.88 per share. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$1.52. So it may not tell us anything about how insiders feel about the current share price.

In the last twelve months insiders purchased 750.00k shares for US$960k. But insiders sold 36.44m shares worth US$79m. Over the last year we saw more insider selling of Ginkgo Bioworks Holdings shares, than buying. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

I will like Ginkgo Bioworks Holdings better if I see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Insider Ownership

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. We usually like to see fairly high levels of insider ownership. Ginkgo Bioworks Holdings insiders own 20% of the company, currently worth about US$636m based on the recent share price. I like to see this level of insider ownership, because it increases the chances that management are thinking about the best interests of shareholders.

So What Does This Data Suggest About Ginkgo Bioworks Holdings Insiders?

The recent insider purchases are heartening. However, the longer term transactions are not so encouraging. The recent buying by some insiders , along with high insider ownership, suggest that Ginkgo Bioworks Holdings insiders are fairly aligned, and optimistic. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Ginkgo Bioworks Holdings. To assist with this, we've discovered 3 warning signs that you should run your eye over to get a better picture of Ginkgo Bioworks Holdings.

But note: Ginkgo Bioworks Holdings may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.